Inflammation and cardiovascular risk

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: K. Alhabib, I. Seropian

Speakers: S. Garzon, S. Charfeddine, J. Chai, M. Stracqualursi, Z. Ma, U. Sajjad

Summary

Exploring the interplay between inflammation and cardiovascular risk, this session reviews contemporary research on residual risk post-PCI, inflammatory markers in coronary artery disease especially in type 2 diabetes and ACS, and prognostic tools including lipoprotein(a) and systemic inflammation indices.

Presentations available when logged in:

Contemporary PCI in octogenarians: a propensity-matched analysis from 51,271 patients
Residual cardiovascular risk after contemporary PCI
Association of inflammation and extent of coronary artery disease in type 2 diabetes and ACS
Predictive value of the TyG and systemic inflammation for MACE: a ten-year prospective cohort study
Age-stratified performance of the MIRACLE2 score for neurological outcome prediction after out-of-hospital cardiac arrest

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Inflammation and cardiovascular risk

Session comprising selected EuroPCR 2026 abstract submissions

Log in or create account for free